HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuki Matsui Selected Research

2- (((amino(imino)methyl)amino)carbonyl)- 1- methyl- 4- trifluoromethyl- 1H- indol- 7- yl- hydrogen- sulfate monohydrate

10/2005Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits.
10/2004Differences in the effects of Na+-H+ exchange inhibitors on cardiac function and apoptosis in guinea-pig ischemia-reperfused hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuki Matsui Research Topics

Disease

5Pain (Aches)
02/2021 - 07/2019
4Hypersensitivity (Allergy)
02/2021 - 05/2020
4Hyperalgesia
01/2021 - 07/2019
4Ischemia
10/2005 - 04/2002
3Visceral Pain
01/2021 - 07/2019
3Infarction (Infarctions)
10/2005 - 04/2002
3Myocardial Infarction
10/2005 - 02/2002
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
11/2020 - 05/2020
2Hypertension (High Blood Pressure)
01/2012 - 01/2011
2Reperfusion Injury
05/2005 - 10/2004
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Atrial Fibrillation
01/2021
1Torsades de Pointes (Torsade de Pointes)
01/2021
1Diarrhea
05/2020
1Neoplasms (Cancer)
08/2015
1Fibrosis (Cirrhosis)
01/2012
1Myocarditis (Carditis)
09/2011
1Inflammation (Inflammations)
09/2011
1Heart Failure
01/2011
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2005
1Heart Injuries
10/2005

Drug/Important Bio-Agent (IBA)

3AcidsIBA
08/2015 - 10/2004
2T-Type Calcium Channels (T-Type Calcium Channel)IBA
02/2021 - 11/2020
2Butyrates (Butyrate)IBA
02/2021 - 11/2020
2Bepridil (Vascor)FDA Link
01/2021 - 01/2021
2sodium sulfideIBA
11/2020 - 07/2019
2N- 4,4- dimethyl- 2- thioxo- 1,4- dihydro- 2H- 3,1- benzoxazin- 6- ylthiophene- 2- sulfonamideIBA
01/2012 - 01/2011
22- (((amino(imino)methyl)amino)carbonyl)- 1- methyl- 4- trifluoromethyl- 1H- indol- 7- yl- hydrogen- sulfate monohydrateIBA
10/2005 - 10/2004
2Nicorandil (SG 75)IBA
10/2005 - 02/2002
2indoleIBA
10/2004 - 04/2002
2SM 20550IBA
04/2002 - 04/2002
1Dopamine D2 Receptor AntagonistsIBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1Dihydrotachysterol (AT 10)IBA
01/2021
1Pimozide (Orap)FDA Link
01/2021
1Sulfonic AcidsIBA
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1sym-trinitrobenzeneIBA
01/2021
1Protein Isoforms (Isoforms)IBA
11/2020
1PAR-2 ReceptorIBA
11/2020
1Calcineurin InhibitorsIBA
05/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2020
1CalcineurinIBA
05/2020
1capsazepineIBA
05/2020
1Tacrolimus (Prograf)FDA LinkGeneric
05/2020
1Capsaicin (Zostrix)FDA Link
05/2020
1Calcium Channels (Calcium Channel)IBA
07/2019
12- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA
07/2019
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
07/2019
1Tyrosine Kinase InhibitorsIBA
08/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2015
1Dasatinib (BMS 354825)FDA Link
08/2015
1Reducing AgentsIBA
08/2015
1AldosteroneIBA
01/2012
1SaltsIBA
01/2012
1InterleukinsIBA
09/2011
1Interleukin-6 (Interleukin 6)IBA
09/2011
1Eplerenone (Inspra)FDA LinkGeneric
01/2011
1Spironolactone (Aldactone)FDA LinkGeneric
01/2011
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2011
1Sulfates (Sulfates, Inorganic)IBA
10/2005
1HydrogenIBA
10/2005
1cariporideIBA
05/2005
1Creatine Kinase (Creatine Phosphokinase)IBA
05/2005
1Caspase 3 (Caspase-3)IBA
10/2004
1Adenosine Triphosphate (ATP)IBA
10/2004
1AntioxidantsIBA
10/2004
1Oxygen (Dioxygen)IBA
04/2002
1methanesulfonic acid (methanesulfonate)IBA
04/2002
1Nifedipine (Adalat)FDA LinkGeneric
02/2002
1Propranolol (Inderal)FDA LinkGeneric
02/2002
1SMP-300IBA
02/2002

Therapy/Procedure

1Intravenous Administration
10/2005